Maricann Announces Appointment of New Chief Financial Officer
Original Post: TORONTO, Ontario (October 3, 2017)
Maricann Group Inc. (CSE: MARI, OTCQB: MRRCF, FRA: 75M) (“Maricann” or the “Company”) is pleased to announce the appointment of Scott Langille as the Company’s Chief Financial Officer effective October 2, 2017, subject to regulatory approval.
Mr. Langille has over 30 years of experience in the pharmaceutical industry in both Canada and the United States.
To learn more CLick-Here
Origianl Post on maricann.com